Heterogeneity of PD-L1 expression: Correlation of immunohistochemical PD-L1 expression and genetic profile with 99mTc-iPD-L1 SPECT/CT in patients with metastatic non-small cell lung cancer

被引：0
|
作者：
Garcia-Perez, O. [1 ]
Michel Sanchez, E. [1 ]
Cabrera Miranda, L. [1 ]
Ferro Flores, G. [1 ]
Soldevilla Gallardo, I. [1 ]
Gonzalez Rueda, S. [1 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-194
引用
收藏
页码：S303 / S304
页数：2
相关论文
共 50 条
  • [21] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [22] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [23] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [24] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [25] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] PD-L1 expression in driver-mutated metastatic non-small cell lung cancer
    de Jager, V.
    Garcia, B. N. Cajiao
    Hempenius, M. A.
    Kuijpers, C. C.
    van Kempen, L. C.
    Schuuring, E.
    van der Wekken, A. J.
    Willems, S. M.
    VIRCHOWS ARCHIV, 2024, 485 : S139 - S139
  • [27] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
    Munari, Enrico
    Zamboni, Giuseppe
    Marconi, Marcella
    Sommaggio, Marco
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Moretta, Francesca
    Mingari, Maria Cristina
    Salgarello, Matteo
    Terzi, Alberto
    Picece, Vincenzo
    Pomari, Carlo
    Lunardi, Gianluigi
    Cavazza, Alberto
    Rossi, Giulio
    Moretta, Lorenzo
    Bogina, Giuseppe
    ONCOTARGET, 2017, 8 (52): : 90123 - 90131
  • [28] SPECT/CT imaging of PD-L1 expression in non-small cell lung cancer based on 99Tc~m labeled anti-PD-L1 nanoantibodies
    邢岩
    China Medical Abstracts(Internal Medicine), 2022, 39 (02) : 66 - 67
  • [29] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [30] The correlation between PD-L1 expression and metabolic parameters of 18FDG PET/CT and the prognostic value of PD-L1 in non-small cell lung cancer
    Xu, Xin
    Li, Jihui
    Yang, Yi
    Sang, Shibiao
    Deng, Shengming
    CLINICAL IMAGING, 2022, 89 : 120 - 127
12345